Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
NCT ID: NCT01023698
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
30 participants
INTERVENTIONAL
2009-04-30
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
NCT00802269
Safety and Efficacy of Low-Fluence PRP for PDR
NCT01737957
Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage
NCT05318742
Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
NCT00563043
Changes in Macular Thickness After Patterns Scan Laser
NCT00563628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
photocoagulation
Laser photocoagulation
laser photocoagulation
Laser photocoagulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laser photocoagulation
Laser photocoagulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación para Evitar la Ceguera en México
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria A Martinez-Castellanos, MD
Role: PRINCIPAL_INVESTIGATOR
Asociacion para Evitar la Ceguera en México
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEC0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.